Tue, Feb 9, 2010

The 11th Annual NATA Symposium in Barcelona

The Network for Advancement of Transfusion Alternatives (NATA) is hosting its 11th Annual two-day conference on April 8 and ...  More

European Hematology Association Scientific Workshop Focuses on Innovative Therapies for Red Cell and Iron Related Disorders

The European Hematology Association is hosting a scientific workshop in Cascais, Portugal, on April 15-18, 2010 to discuss ...  More

New study results indicate that the novel, synthetic, peptide-based erythropoietin-receptor agonist—Hematide, Affymax—is effective

The stimulation of neutralizing antierythropoietin antibodies is a rare complication of recombinant human erythropoietin use ...  More

Pivotal study points to limited effect of darbepoetin alfa on clinical outcomes in anemic patients with chronic kidney disease.

The data from this pivotal study, lead Pfeffer, et al., to conclude that: “for many persons involved in clinical decision ...  More

Anemia of Inflammation—An Enigma Resolved?

An intriguing phenomenon associated with anemia of inflammation is that approximately 70% of patients with inflammation have ...  More

Is Normalising Haemoglobin in Patients with CKD Harmful? And if so, Why?

J Renal Care Volume 35, Issue s2, Pages 25-9 (December 2009) “Managing the current issues in anaemia and iron therapy in Chronic Kidney Disease.”

In this special supplement of the Journal of Renal Care, T. J. Littlewood reviews the evidence that correction of anemia in patients with chronic kidney disease using erythropoiesis stimulating agents increases hemoglobin levels, reduces transfusion rates, and improves their quality of life and life expectancy, when the ...
...

Full article >>

March 3 to 10, 2010

St. Louis, Missouri, USA

SSO Annual Cancer Symposium

www.surgonc.org/default.aspx?id=39

April 8 to 9, 2010

Barcelona, Spain

11th Annual Network for the Advancement of Transfusion Alternatives - NATA

www.nataonline.com

April 15 to 18, 2010

Cascais, Portugal

ESH-EHA Scientific Workshop-Innovative Therapies For Red Cell And Iron Related Disorders

www.esh.org

May 25 to 28, 2010

Lausanne, Switzerland

XV International Congress on Nutrition and Metabolism in Renal Disease

www.isrnm-lausanne2010.org

This site complies with the HONcode standard for trustworthy health information:
verify here.